Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
FEMASYS INC (FEMY)
Standardized SEC financial data for FEMASYS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001339005 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Gross margin
62.0%
Operating margin
-767.0%
Net margin
-812.3%
Revenue growth (YoY)
40.8%
Return on equity
-317.4%
Free cash flow
-$19.2M
Current ratio
4.53×
EPS (diluted)
$-0.47
Ratios for fiscal year 2025, standardized from SEC filings.